Characterization of an antigen of Neisseria gonorrhoeae by Milner, Eric Charles
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
1976 
Characterization of an antigen of Neisseria gonorrhoeae 
Eric Charles Milner 
The University of Montana 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
Let us know how access to this document benefits you. 
Recommended Citation 
Milner, Eric Charles, "Characterization of an antigen of Neisseria gonorrhoeae" (1976). Graduate Student 
Theses, Dissertations, & Professional Papers. 1780. 
https://scholarworks.umt.edu/etd/1780 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
CHARACTERIZATION OF AN ANTIGEN OF 
NEISSERIA GONORRHOEAE 
by 
Eric C. B. Milner 
A.B., University of California, 1972 
Presented in partial fulfillment of the requirements 
for the degree of 
Master of Science 
UNIVERSITY OF MONTANA 
1976 
Approved by: 
Chairman, Board of Examiners 
ea^ Graduate School ' 
UMI Number: EP34630 
All rights reserved 
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent on the quality of the copy submitted. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed, 
a note will indicate the deletion. 
UMT 
DltufUMon PubMaWng 
UMI EP34630 
Copyright 2012 by ProQuest LLC. 
All rights reserved. This edition of the work is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuesf 
ProQuest LLC. 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
Milner, Eric C. B., M.S., June, 1976 Microbiology 
Characterization of an Antigen of Neisseria gonorrhoeae (97 pp.) 
D i r e c t o r :  J o n  A .  R u d b a c h  H u x  
The increasing incidence of gonococcal infection in the United 
States is due in large part to the reservoir formed by the large 
number of female and male asymptomatic carriers. Control of the 
disease would be facilitated by a rapid diagnostic test suitable 
for screening the general population for asymptomatic carriers. 
A radioimmunoassay which employs an antigen specific for 
Neisseria gonorrhoeae contained in an ethanol precipitate of a 
surfactant extract of T1 phase gonococci recently has been de­
veloped for the detection of antibodies specific for the gono-
coccus in human serum. In the present project, the chemical, 
physical, and biological properties of the gonococcal specific 
antigen were studied. In a major portion of this work an inhi­
bition assay was employed. Treatments designed to destroy or al­
ter specifically various components were performed on unlabeled 
antigen. This treated antigen was then tested for capacitiy to 
inhibit the specific binding of labeled antigen by human anti-
gonococcal serum. It was found that gonococcal specific anti­
genic activity was destroyed by boiling for 5 min, by digestion 
with proteolytic enzymes, and by periodate oxidation. Antigenic 
activity was not destroyed by heating at 56 C for 1 hr, by treat­
ment with 0.1 N acid or alkali, by saponification, or by diges­
tion with ribonuclease or deoxyribonuclease. It was found that 
the specific antigen was not contained in T3 phase gonococci or 
in an endotoxin preparation of T1 phase gonococci. A fraction 
containing specific antigenic activity was eluted in the void 
volume from Sephadex G-200. Fractions containing specific anti­
genic activity were found in the regions of 40% and 10% sucrose 
following untracentrifugation on a sucrose gradient. 
A model for the structure of the gonococcal specific antigen 
was proposed which could account for these findings. 
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CHAPTER I 
INTRODUCTION 
Gonorrhea is the number one reportable infectious disease in the 
United States today (9, 49). While treatment of the disease is rela­
tively simple, diagnosis can be difficult (63). In females, even with 
acute infection, symptoms may be absent or go unnoticed, so that many 
women go untreated and become chronic, asymptomatic carriers (35). In 
males, although symptoms are more often noticed and treatment sought, 
the rate of asynçtomatic carriers is surprisingly high (21). It has 
been reported that as many as 68% of infected males may be asymptomatic 
(21). Present diagnostic procedures which include culturing (32, 62), 
gram staining smears and fluorescent antibody techniques (14, 18, 32, 64, 
66, cf. 55), are expensive and time consuming. This renders them im­
practical for screening large numbers of people (63). These procedures 
are usually not performed unless gonorrhea is suspected, either from 
overt symptoms or a history of sexual contact with an individual known 
to be infected. Because the great number of asymptomatic carriers form 
a reservoir from which the disease is disseminated, eradication will not 
be achieved until a method is available which is suitable for screening 
the general population for carriers (57). A blood test, because of the 
ease of sample collection and social acceptability, would be ideal. 
1 
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Numerous investigators have studied the gonococcus with the aim of 
finding an antigenic component which would provide a reagent suitable 
for detecting humoral antibodies specific for the gonococcus. This 
would be the first step toward development of a sérodiagnostic test for 
gonorrhea. Among the antigens studied have been whole cells (14, 37), 
protoplasm (2, 3, 11, 13, 29, 30, 51, 54, 58), pili (8, 52), endotoxin 
(17, 38-46, 61), and ribosomes (26). Whole cells (64, 66) and proto­
plasmic extracts (2, 3, 11, 13, 30, 51, 54, 58) have been used in com­
plement fixation and gel diffusion tests. Antibodies in the serum of 
patients have been found which reacted with these preparations, but no 
assay has been clinically acceptable. Major problems encountered with 
seroassays have been high rates of false positive reactions (3, 14, 30, 
33, 37, 53), high rates of false negative reactions (3, 23, 33, 37), 
and lack of sensitivity (23, 54, cf. 55). Also, antisera to species of 
Neisseria other than gonococci cross react extensively with these anti­
gens (33). 
Two antigenic fractions of gonococcal endotoxin have been charac­
terized which react in complement fixation and gel diffusion tests (38). 
One fraction, "3", cross reacted extensively with other Neisseris (39, 
42). The other fraction, "a", demonstrated some specificity for the 
gonococcus (39, 42). Fraction "a" has not, however, been shown to be 
any more reliable than the whole cell or protoplasmic antigens for use 
in diagnostic assays for gonorrhea. 
Gonococcal pili have been used in a radioimmunoassay by Buchanon 
et al. (8) with some success. Other investigators (50) have shown that 
pili are highly strain specific, a finding which, if confirmed, would 
limit the usefulness of pili in a diagnostic test. 
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Gonococcal ribosomes have been used successfully in delayed hyper­
sensitivity (DH) type skin tests with animals immunized with N. gonor­
rhoeae (26). Usefulness of delayed skin tests in diagnosis of gonococcal 
infection in human patients has not been shown. 
More recently a disrupted cell extract has been used in a radio­
immunoassay for the detection of specific antibodies against the gono-
coccus in human sera (36). A high degree of specificity has been ob­
tained with this antigen. In a study of sera from 382 patients, 90% were 
correctly diagnosed, 5% were incorrectly diagnosed and 5% could not be 
diagnosed as either positive or negative (36). These results were equal 
to or superior to results reported for the serological diagnosis of 
gonorrhea ençloying pili antigens (8). 
The objective of this research project was to characterize the 
specific antigen contained in the disrupted cell extract and, if possible, 
to purify the antigen from the crude extract. The goal of characteriza­
tion was to elucidate the chemical and physical nature of the gonococcal 
specific antigen, to measure its biological properties and to test the 
stability of the antigen to various treatments. It was hoped that such 
a study would increase the knowledge of specific antigens on the gono-
coccus and would lead to procedures for purification of the antigen. 
Purification of the antigen would increase the specificity of the assay 
for the diagnosis of gonococcal infection. 
Several properties of the model system enqiloyed in this study 
rendered efforts to characterize the antigen more difficult. Perhaps 
the greatest hindrance was that all work was performed with human sera 
rather than antisera obtained from artificially immunized animals. The 
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human serum model required that the assay system had to be capable of 
detecting very low antibody levels. This eliminated gel precipitation 
or flocculation assays as adjuncts to characterization procedures. Also, 
because of the low antibody titers and the extreme sensitivity required 
of the assay, non-specific reactions in some cases overshadowed specific 
reactions. This created problems of interpretation of assay results. 
However, because humans are the only species infected naturally by the 
gonococcus (34) and because results from previous work with animal models 
of gonococcal infection have not been shown to apply to the human system, 
it was felt that despite the difficulties, a study of the human system 
was amply justified. 
Another property of the system which was to be studied was the com­
plex nature of the antigenic extract. The specific antigen probably was 
only a fraction of the crude extract. Non-specific antigens in the ex­
tract could react with antibodies in the human sera and, thus, affect 
the assay results. If such non-specific reactions occurred it would be 
difficult to know if an experimentally determined characteristic was a 
property of the specific gonococcal fraction or was a property of other 
material contained in the extract. A possible way to overcome this pro­
blem would have been to purify the specific gonococcal antigen before 
attempting to characterize it. This approach was not taken, however, 
because it was felt that attempts to purify an unknown entity could 
easily turn out to be a fruitless, time-consuming endeavor. Therefore, 
an inhibition assay, which allowed study of the specific antigen in the 
presence of other materials, was employed for most determinations of 
antigenic activity. In some cases a direct assay of antigenic activity 
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also was enç)loyed to add confidence to interpretation of results obtained 
with the inhibition assay. 
In order to characterize the gonococcal specific antigen it was 
necessary to determine the chemical, physical, and biological properties 
of the antigenic extract. Also, it was necessary to study the relation­
ship of these properties to gonococcal specific antigenic activity. 
Finally, it was hoped that the experimentally determined characteristics 
could be used to propose a model for the structure of the gonococcal 
specific antigen. 
CHAPTER II 
MATERIALS AND METHODS 
Gonococcal strains 
Neisseria gonorrhoeae strain F62 was obtained from Dr. D. S. Kellogg, 
Jr., Center for Disease Control, Atlanta, GA. In addition, a strain 
freshly isolated from an infected patient was obtained from the Infec­
tious Disease Center, Missoula, MT, and designated strain IDC. 
Maintenance and cultivation of organisms 
Strain F62 organisms were stored in lyophilized form. Both strain 
F62 and strain IDC were stored for short periods (up to 4 weeks) at 
-20*C in a special freezing medium containing Eagle minimum essential 
medium plus 20% glycerol, pH 7.0. 
During periods of frequent use, the cultures were maintained on 
GC Medium Agar Base (Difco, Detroit, MI.) supplemented with 1% IsoVitalex 
(Bioquest, Cockeysville, MD.). T1 phase colonies of strain F62 and T3 
phase colonies of strain IDC were selected and transferred daily. Plates 
were incubated 18 h at 37°C in a candle extinction jar. 
For extraction, cultures were grown in modified Thayer-Mart in broth 
medium (62) containing 15 g proteose peptone #3 (Difco), 4 g K2HPO4, 
0.1 g cornstarch, and 5 g NaCl in 1 1 deionized distilled water (DDW). 
The pH was adjusted to 7.2 with HCl. The medium was supplemented with 
6 
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sterile calf serum to 5% (v/v) prior to inoculation. Scrapings from an 
18 h plate culture were inoculated into one 1 broth in a wide bottom two 1 
flask. Cultures were gassed with a mixture of 83% N2, 7% O2, and 10% 
CO2 and incubated 24 or 48 h at 37*C with gentle rotation. After incu­
bation, each broth culture routinely was checked for purity by Gram 
staining and plating. Extraction procedures were initiated if no con­
tamination was revealed by the Gram stain. Plates were examined the 
following day as a check on purity, and to determine the distribution of 
gonococcal colony types. 
Preparation of antigenic extracts 
Cells from a 24 or 48 h broth culture were harvested by centrifuga-
tion and washed with 0.1 M Tris-HCl buffer, pH 8.0 (Tris). The washed 
cells from one 1 of medium were suspended in 25 ml of 2% sodium deoxy-
cholate in Tris and allowed to stand at room temperature for 1.5 h. The 
disrupted cells were then centrifuged for 30 min at 27,000 X£ and 25*C. 
The antigen was precipitated by decanting the supernatant fluid (SF) 
into six volumes of 95% ethanol and allowing the precipitate to develop 
overnight at room tençerature. Strands of nucleic acid were removed by 
winding onto a wooden stick. Additional nucleic acid floccules were re­
moved from the precipitate by filtration onto gauze. The filtrate was 
centrifuged at 1500 X £ for 30 min to separate out an insoluble fraction. 
This pellet was suspended in 15 ml distilled water and recentrifuged at 
27,000 X £ for 30 min to sediment a particulate fraction. The super­
natant fluid from the final centrifugation (containing the soluble anti­
gen) was transferred to dialysis tubing and dialyzed for 5 days against 
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daily changes of distilled water at 4°C. After dialysis, the antigen 
was lyophilized. The product of this extraction procedure was designated 
GCE. 
Labeling of antigens 
Several batches of GCE were labeled with (irvine, CA) by the 
method of Gruber and Wright (20). Briefly, in this technique, a modified 
Conway microdiffusion cell was made by cutting the top from a 1 dram vial 
and placing the bottom half into a 125 ml Erlenmeyer flask; this formed 
a separate inner chamber. The antigen solution to be labeled was pipetted 
into the outer chamber. Then 0.2 ml of 0.002 M KI and 500 y Ci of 
were added to the inner chamber. The flask was sealed with a skirt-type 
vaccine stopper. Two-tenths ml of a 1/20 dilution of 0.27 M Na2Cr20y in 
36 N H2SO4 was added to the inner chamber with a syringe and four inch 
needle. The flask was allowed to sit at room temperature for 1 to 3 h 
with occasional gentle shaking. The labeled antigen (GCE*) was separated 
from the free 125i by dialysis against four daily changes of one 1 PBS. 
All work was performed behind lead shielding. 
Human serum source 
Two human serum pools were employed. One pool was prepared by mix­
ing, in varying proportions, sera obtained from a local blood bank so 
that when it was reacted with the gonococcal antigen in the radioimmuno­
assay, it gave an activity ratio similar to that obtained with serum 
samples from anatomically virginal females; it was designated VI. 
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A positive serum pool was obtained from blood drawn from a 24 year 
old Caucasian female. This individual had been culturally positive for 
N. gonorrhoeae 3 times and had been treated for gonorrhea two additional 
times. The patient was in average general health. This pool of serum 
was designated R-65. 
Preparation of anti-immunoglobulin 
Antiserum to human gamma globulin was prepared by injecting New 
Zealand white rabbits on day 1 with 4 mg of Cohn Fraction II of pooled 
human sera (Cutter Laboratories, Berkeley, CA), as follows: 1 mg intra­
venously suspended in saline, 1 mg intraperitoneally suspended in saline, 
and 2 mg intramuscularly suspended in an equal volume Conq)lete Freund 
Adjuvant (Difco, Detroit, MI). The rabbits were then injected intra­
muscularly at weekly intervals with 2 mg protein in Conç)lete Freund 
Adjuvant. Rabbits were bled by cardiac puncture at the end of the fifth 
week. Following the initial bleeding, the rabbits were alternately bled 
and boosted at weekly intervals. 
Radioimmunoassay 
The reaction mixture for assaying the specific antigonococcal reac­
tion (SAGR) of the serum samples consisted of 0.5 ml of phosphate buf­
fered saline (0.15 M NaCl, 0.0033 M PO^; pH 7.2) (PBS), 20 y1 human 
serum, and 10 yl labeled antigen solution containing 1 yg GCE* in a 12 ml 
conical centrifuge tube. Following an initial incubation, precipitation 
was induced by the addition of anti-human immunoglobulin. Eppendorf 
microliter pipets (Brinkman Instruments, Inc., Westbury, NY) were employed 
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to disperse the serum and the antigen solutions. The assay procedure is 
outlined in Figure 1. 
Inhibition assay 
The inhibition assay was used to measure the effects of various 
treatments on GCE. Each inhibition assay included nine reaction mixtures: 
An uninhibited control, four standards containing untreated GCE, and four 
experimental tubes containing treated GCE. The assay was set up accord­
ing to the protocol outlined in Figure 2 and assayed as described in 
Figure 3. The activity ratios were calculated for each reaction mixture. 
If the unlabeled GCE inhibited the binding of GCE* there would be a de­
crease in the value of the activity ratio. Inhibition curves were ob­
tained from a plot of the values of the activity ratios against the log 
of the amounts of inhibitor added. 
In order to compare inhibition curves from different assays, the 
inhibition curves were normalized. This normalization was accomplished 
by designating the activity ratio of the uninhibited control as 100% of 
control binding and designating the lowest activity ratio obtained by 
inhibition with untreated GCE as 0% of control binding. The values of 
the remaining activity ratios were graphed proportionally as percentage 
values. The experimental curve, thus, was plotted relative to the stan­
dard curve. This procedure always resulted in a standard curve showing 
a decrease in percent of control binding from 100% to 0% as the amount 
of untreated GCE inhibitor was increased incrementally from 0.0 yg to 
10.0 yg. The amount of inhibitor added which resulted in a 50% inhibi­
tion of control binding was determined by visual inspection of the graph 
Figure 1. Specific antigonococcal reaction (SAGR) 
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10 pi GCE* (^25J labeled GCE) added to 20 yl human serum in 0.5 ml PBS 
and mixed gently 
+ 
Incubate 30 min, 37"C 
4-
0.25 ml rabbit anti-human immunoglobulin added 
4-
Incubate 30 min, 37®C and 18 h, 4°C 
+ 
Separate precipitate (PPT) from supernatant fluid (SF) by centrifugation 
at 1000 X 30 min, 4'C 
4 
PPT washed 3X in ice-cold PBS; SF decanted and 100 yl saved for analysis 
+ 
PPT and 100 yl SF counted in a manual crystal scintillation unit at a 
voltage in the Geiger-MOller region (1064 volts). 
4-
The ratio of bound (precipitated) to a total of bound plus unbound anti­
gen was determined form the following formula: 
Activity ratio = cpm PPT - Background (BKG) 
Activity ratio ppT _ cpm BKG + cpm 100 yl SF - cpm BKG 
Figure 2. Protocol for inhibition assays. 
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Standards* Experimental^ Control 
Tube # 12345678 9 
Human serum, ul 20 20 20 20 20 20 20 20 20 
Untreated GCE, pg 0.2 1.0 5.0 10.0 
Treated GCE, yg — — — — 0.2 1.0 5.0 10.0 
PBS Volume of all tubes adjusted to 0.52 ml 
Assayed as outlined in Figure 3. 
^Untreated GCE employed in preparation of standard curve 
^Treated GCE 
Figure 3. Assay procedure for inhibition 
of specific antigonococcal reaction. 
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Inhibitor pre-incubated 30 min, 37°C with 20 ml human serum 
+ 
10 yl GCE* (IZS; labelled GCE) added 
i 
Incubate 30 min at 37*C 
0.25 ml rabbit anti-human immunoglobulin added 
4-
Incubate 30 min at 37*C and 18 h at 4°C 
+ 
Separate PPT from SF by centrifugation at 1000 X £ for 30 min at 4*C. 
+ 
PPT washed 3X in ice-cold PBS; SF decanted and 100 pi saved for analysis. 
PPT and 100 yl SF counted in a manual crystal scintillation unit at a 
voltage in the Geiger-Miiller region (1060 volts). 
The ratio of bound (precipitated) to a total of bound plus unbound anti­
gen was determined from the following formula: 
Activity ratio = cpm in PPT - Background (BKG) 
Activity ratio ppT - cpm BKG + cpm in SF - cpm BKG 
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and designated the IA50. By the nature of the normalization procedure 
the value of the IA50 of the standard curves was approximately 1.0 yg. 
The value of the IA50 of the experimental curves varied widely depending 
on the treatment performed on GCE. The capacity of treated GCE to inhi­
bit SAGR was expressed as a percent of the capacity of untreated GCE to 
inhibit SAGR according to the following formula: 
% of standard inhibition = 100 X FLASP untreated GCEI^ 
tiAso treated GCE J 
The percentage value obtained from this formula was a measure of the 
effect of the treatment on GCE. 
Nitrogen determination 
Organic nitrogen was converted to inorganic nitrogen by Kjeldahl 
digestion (cf. 27). Inorganic nitrogen was estimated by the Messier 
reaction as modified by Johnson (25a). Ammonium sulfate nitrogen stan­
dards and reagent blanks were carried through the entire procedure. 
Protein content was calculated assuming 16% nitrogen. 
Protein determination 
Protein content of GCE was estimated by the method of Lowry et ai. 
cf. 27). Solutions of 2% Na^COg in 0.10 N NaOHandO.5% CuSOj-SH^O in 
1% sodium tartrate were prepared. Subsequently, 1 ml of the copper 
solution was added to 50 ml of the Na2C03-Na0H just before the reagent 
was to be used. Then 2.5 ml of this reagent was added to 0.5 ml protein 
(10-100 lig). After 10 min at room temperature, 0.25 ml of Folin reagent 
diluted to 1 N was added with vigorous mixing. Reagent blanks and bovine 
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serum albumin standards were treated similarly. After 30 min at room 
tençerature the solutions were read against a reagent blank on a Beckman 
DU-2 spectrophotometer at a wavelength of 650 nm. 
DNA determination 
DNA content of GCE was estimated by the diphenylamine reaction 
(cf. 27). Diphenyleunine reagent was prepared by dissolving 1.5 g diphen-
ylamine in 100 ml glacial acetic acid followed by the addition of 1.5 ml 
concentrated H2SO4. Then 0.10 ml aqueous acetaldehyde (16 mg/ml) was 
added per 20 ml of the above solution. Two ml of this latter reagent 
was mixed with 1 ml DNA (10-200 yg) and the tubes were heated for 10 min 
in a boiling water bath. Blanks and DNA standards (calf thymus DNA, 
highly polymerized, Sigma Chemical Conqjany, St. Louis MO) were treated 
similarly. Tubes were cooled and read at 600 nm on a Beckman DU-2 spec­
trophotometer against a reagent blank. DNA content was determined by 
interpolation from a standard curve prepared by plotting absorbancies 
obtained with varying amounts of a standard DNA solution. 
RNA determination 
RNA content of GCE was estimated by the orcinol reaction for pentose 
determination (cf. 27). The orcinol reagent was prepared by mixing 1 
volume of a solution of 1.6 g orcinol in 100 ml H2O with 7.5 volumes of 
21.6 N H2SO4. Two ml of this orcinol reagent was mixed with 1 ml RNA 
(10-100 yg). The tubes were heated for 20 min in a boiling water bath. 
Reagent blanks and RNA standards (yeast RNA, Schwartz/Mann, Orangeburg, 
NY) were treated similarly. The tubes were cooled and read at 640 nm 
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against a reagent blank on a Beckman DU-2 spectrophotometer. RNA content 
was determined by interpolation from a standard curve prepared by plot­
ting absorbancies obtained with varying amounts of a standard RNA solu­
tion. 
Ultraviolet absorption spectra 
The absorbance of 100 yg/ml samples of GCE were measured in a Beckman 
DU-2 spectrophotometer at wavelengths of 220 nm to 320 nm. The 260/280 
ratio was used to estimate protein content and nucleic acid content of 
the antigen extractions according to the absorbance relationships deter­
mined by Warburg and Christian (65). 
Sephadex chromatography 
Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Piscataway, NJ) was 
suspended in PBS and allowed to swell overnight. The slurry was dearated 
by vacuum and then packed in a 30 cm x 1 cm column. A 0.25 ml sample 
(containing 25 ug GCE labeled with 125j PBS) was layered on the column 
and eluted with PBS, pH 7.2. One ml fractions were collected at a rate 
of 0.5 ml/mg and analyzed for total radioactivity. Fractions containing 
2000 cpm/ml or over were assayed for reactivity with the standard positive 
serum (R65). 
Sucrose velocity gradient ultracentrifugation 
Sucrose velocity gradient ultracentrifugation was used in an attempt 
to separate components of the crude antigen extract. A 10% to 50% dis­
continuous sucrose gradient was prepared in 13 ml polyallomer tubes. 
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Then 0.4 ml GCE* in 10% sucrose was layered on the top of the gradient. 
Following ultracentrifugation in a Beckman L2-65B ultracentrifuge at 
100,000 X £ for 16 h at 4®C in a Spinco type 65 rotor, 12-drop fractions 
were collected from the bottom of the tubes and these fractions were 
analyzed for total radioactivity. Fractions containing 2000 cpm/ml or 
over were dialyzed against PBS for 4 days and assayed for reactivity 
with the standard positive serum. Samples from each fraction were anal­
yzed for sucrose concentration by the anthrone reaction (cf. 27]. 
Physical and chemical treatments 
In experiments where the effects of the treatment on GCE were mea­
sured by the inhibition assay treatments were performed on 20 yg GCE. 
Following the treatment the volume was adjusted to 1 ml and divided into 
samples containing 10, 5, 1, and 0.2 yg GCE. Each sample was adjusted 
to a final volume of 0.5 ml with PBS and assayed by the previously de­
scribed inhibition assay (cf. Figure 2). 
In some experiments treatments were performed on labeled GCE (GCE*). 
In these experiments 20 yg GCE* was treated. Following treatment the 
volume was adjusted to 1.0 ml and 0.5 ml aliquots were assayed directly 
for reactivity with the positive human serum. 
Heat stability. Twenty yg GCE in 1 ml PBS was heated in a boiling water 
for 2 min or 1 h. Other samples were heated at 56"C for 1 h and assayed 
as described above (cf. Figure 2). 
pH stability. Twenty yg GCE in 20 yl PBS was incubated for 1 h at 23-
25*C with 0.25 ml 0.1 N HCl. Following incubation the reaction mixture 
was neutralized with 25 y eq NaOH and the volume was adjusted to 1.0 ml 
with PBS. The effects of the treatment were determined by the inhibition 
assay (cf. Figure 2). Stability to treatment with base was determined 
similarly, incubating with 0.1 N NaOH and neutralizing with HCl. 
Trypsin digestion. Twenty yg GCE and 100 pg trypsin. Nutritional Bio-
chemicals Corporation, Cleveland, OH, (2X crystalline, 50% MgSO^), in 
1 ml PBS were incubated overnight at 37°C. The reaction was stopped by 
boiling the samples for 2 min and assaying them as above (cf. Figure 2). 
When the treatment was performed on labeled GCE (GCE*), the following 
modifications were employed. Twenty wg GCE* and 20 ug trypsin in 0.14 ml 
PBS were incubated 3.5 h at 37*C. The volume was adjusted to 1.0 ml and 
the reaction was stopped by boiling for 2 min. The effects of the treat­
ment were measured by assaying 0.5 ml aliquots for reactivity with the 
standard human serum. 
Pronase digestion. Pronase (B grade, Calbiochem, Los Angeles, CA) 
treatment was performed in exactly the same manner as the trypsin diges­
tion described above (cf. Figure 2). 
Periodate oxidation. Twenty yg GCE was incubated overnight in the dark 
at room tençerature with 46 yg sodium meta periodate in 1 ml PBS. The 
reaction was stopped by the addition of 20 yg glycerol and assayed as 
above (cf. Figure 2). 
Deoxyribonuclease digestion. Twenty yg GCE was incubated 2 h at 37°C 
with 20 yg DNase (Deoxyribonuclease 1, Crude, Sigma Chemical Company, 
St. Louis, MO) in 0.25 ml PBS pH 5.5. The pH was then adjusted to 7.2 
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and the volume adjusted to 1 ml with 0.1 m tris buffer. Activity was 
assayed as above (cf. Figure 2). 
When the treatment was performed on labeled GCE the following mod­
ifications were employed. Twenty yg GCE* and 20 yg DNase in 0.15 ml PBS 
were incubated 3.5 h at 37*C. The volume was then adjusted to 0.5 ml 
with PBS pH 7.2. Activity was assayed by reactivity with the standard 
positive human serum. 
Ribonuclease digestion. Twenty yg GCE was incubated 2 h at 37°C with 
20 yg RNase (Ribonuclease-A, Sigma Chemical Company, St. Louis, MO) in 
0.25 ml PBS pH 5.5. The volume was adjusted to 1 ml and the pH was ad­
justed to 7.2 with 0.1 m tris HCl buffer. Activity was assayed as above 
(cf. Figure 2). 
When the treatment was performed on labeled GCE the same modifica­
tions as used in the DNase digestion were employed. 
Saponification. Twenty yg GCE in 20 yl PBS was added to 0.23 ml absolute 
methanol. To this was added 0.25 ml methanol containing 0.2 M KOH. The 
mixture was incubated 1 h at 23-25°C followed by neutralization with 
0,5 m eq DowexSO. The mixture was mixed 15 seconds on a vortex mixer 
the the Dowex beads were allowed to settle. The antigen solution was 
removed with a capillary pipet. Saponified lipids were then extracted 
by the addition of 0.5 ml ether and 0.5 ml water. The tube was mixed 
15 seconds on a vortex mixer and the phases separated by centrifugation 
at 1000 X £ for 10 min at 4°C. The ether phase was discarded and the 
aqueous phase was dialyzed against twice daily changes of PBS for 2 days 
at 4*C. The effects of the treatment were measured by the inhibition 
assay (cf. Figure 2). 
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Electron microscopy 
Heavy suspensions of whole cells of T1 phase F62 and T3 phase IDC 
were obtained by washing the colonies from an 18-24 h plate culture with 
distilled deionized water. Samples of the cell suspensions were mixed 
with an equal volume 3% (w/v) phosphotungstic acid pH 7.2. A drop of 
this mixture was placed on a formvar coated grid. After allowing the 
bacteria to settle on the grid, excess moisture was removed with a cap­
illary pipet. The grids were allowed to air dry and then observed and 
photographed with a Zeiss EM9-S2 electron microscope (Carl Zeiss, West 
Germany). 
Biological tests 
The pyrogenic responses of rabbits to intravenously administered 
GCE and gcLPS were determined by standard procedures leading to deter­
minations of FI40 (dose producing a fever index of 40 cmr) (47, 67). To 
obtain the FI40, groups of 4 rabbits were inoculated with graded doses 
of pyrogen and the temperatures were recorded at intervals for a period 
of 7 h. The individual curves were plotted with 1°C and 1 h each allot­
ted one inch. For each animal the area included between the temperature 
curve and the baseline was obtained in square centimeters by computer. 
This area was called the fever index (FX). The average FX, at each dose 
level, was then plotted against the logarithm of the dose, and the FI^Q, 
or that dose expected to give a FX of 40 cm^, was read from the graph. 
Lethality for chick embryos was estimated as described previously 
(47). Embryos, after 11 days of incubation, were inoculated intraven­
ously with doses contained in 0.1 ml. In each test, ten embryos were 
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inoculated with each of five graded doses, differing by five-fold. The 
results, after an additional 24 h of incubation, were used to calculate 
the median lethal dose for chick embryos (CELD^Q) as described by Irwin 
and Cheeseman (25). 
Extraction of endotoxin from N. gonorrhoeae 
A 48 h flask culture of N. gonorrhoeae was harvested by centrifu-
gation at 1800 X ̂  for 30 min at 4''C and washed once in cold PBS. The 
cells were resuspended in 50 ml DDW and an equal volume of 88% liquid 
phenol (U.S.P., J. T. Baker Chemical Company, Phillipsburg, NJ) was 
added. The mixture was placed in a 65°C water bath and stirred until 
the temperature reached 65°C and the phenol and aqueous phases homogen­
ized. Stirring was continued for another 30 min, and the solution was 
distributed to glass centrifuge tubes, which were then chilled in an 
ice bath overnight to allow the phases to separate. The tubes were cen-
trifuged at 4°C for 60 min at 1800 X g. The aqueous phases, after re­
moval from the inter- and phenol-phases, were combined. An equal volume 
of water was added to the combined phenol and inter-phases and the ex­
traction was repeated; the second aqueous phase was combined with the 
first, and the phenol residues were discarded. The aqueous phases were 
dialyzed against running tap water at about 6°C for seven days and 
against three daily changes of distilled water at 4°C. Sufficient sodium 
acetate was added to the aqueous phases to bring the concentration to 
0.15 M: the solution was cooled and 95% ethanol was added at 4*C, drop-
wise with stirring, to bring the alcohol concentration to 68%. After 
allowing the suspension to stand overnight at 4°C, the precipitate was 
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collected by centrifugation at 1800 X £ for 30 min. The precipitate was 
dissolved in distilled water and lyophilized. The endotoxin produced by 
this method was designated gcLPS. The above procedure was a modification 
of the method of Westphal et ai. (cf. 56). 
CHAPTER III 
RESULTS 
Chemical and biological analyses of GCE 
A radioimmunoassay for the diagnosis of gonorrhea has been developed 
recently (36). The antigen used in this assay was a crude extract of 
whole cells of Neisseria gonorrhoeae strain F62; this extract contained 
at lease one antigenic fraction specific for the gonococcus. The next 
step in refining the assay was to characterize the antigen in the extract 
with the ultimate aim of purifying the antigenic fraction. Also this 
could increase both understanding of the antigenicity of the gonococcus 
and specificity of the seroassay. 
As a first step in the characterization, a limited series of chemi­
cal analyses were performed on various preparations. The analyses were, 
of necessity, limited; the yield from a 1 liter culture was only 1 to 
2 mg GCE. It was decided that a 100 yg sample was the maximum amount 
which would be used for any given assay in order to carry out the maxi­
mal number of tests on a single preparation. If a given substance con­
stituted less than 1% of the preparation, then the assay would have to 
be sensitive to amounts of less than 1 yg in order to detect the sub­
stance. 
As a working hypothesis, based on the extraction procedure and 
some preliminary results (Rudbach, unpublished data), it was felt that 
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the gonococcal specific antigen might be a protoplasmic polypeptide, 
glycoprotein, or nucleoprotein. However, the possibilities existed that 
gonococcal endotoxin or pili could have contributed to the specific anti­
genic reactivity. 
The first analytical data obtained were UV absorption spectra 
(from 220 nm to 320 nm) on several GCE preparations (Figure 4). Protein 
and nucleic acid were estimated from a nomograph based on the relation­
ships described by Warburg and Christian (65). It was found that GCE 
contained from 80% to 90% protein with substantial nucleic acid contam­
ination (Table 1). Several preparations were analyzed for total nitogen 
(cf. 27) and protein was estimated assuming 16% nitrogen (Table 1). By 
this method it was found that GCE contained from 57% to 87% protein. 
More specific assays were then enqjloyed for the estimation of protein 
and nucleic acid. The results are summarized in Table 1. Protein was 
estimated by the Lowry method (cf. 27) to be from 40% to 68%. RNA con­
tent was estimated to be from 6.4% to 37% by the orcinol reaction (cf. 27). 
DNA content was estimated from the diphenylamine reaction (cf. 27) to be 
less than 1.0% in all preparations. 
Since endotoxin (LPS) is a major component in cell walls of gram 
negative bacteria, it was necessary to determine LPS content of GCE. 
The easiest and most sensitive way to do this was through a comparison 
of quantitative bioassays for endotoxin performed on GCE and on LPS ex­
tracted from the gonococcus. A phenol-water extract of gonococci was 
prepared by a modification of the method of Westphal et al. (cf. 56). 
This endotoxin extract was designated gcLPS. Both GCE and gcLPS were 
assayed for endotoxic activities by the quantitative capacity to cause 
Figure 4. UV absorption curves of two GCE preparations 
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Table 1. Chemical analyses of various GCE preparations 
GCE 
Protein 
% 
RNA 
% 
DNA 
% 
Total Nucleic Acid 
% 
gc 2 120.0* ndb nd 18.0* 
57C 
gc 4 90.0* nd nd 51.0* 
86.9^ 
gc 11 70.0* nd nd 55.0* 
gc 22 68.Od 6.4® <1.0^ 6.48 
gc 26 40.Od 26.0® <1.0^ 26.08 
gc 31 45.2^ 37.8® <1.0^ 37.8® 
^Protein and nucleic acid content estimated by UV absorption, 
^nd = not done. 
^Protein estimated from nitrogen content determined by 
Nessler Nitrogen Analysis. 
^Protein estimated by Lowry method. 
®RNA estimated by reaction with orcinol reagent. 
.P 
DNA estimated by reaction with diphenylamine. 
^Nucleic acid as RNA. 
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fever in rabbits and to kill chick embryos (47). The biological activi­
ties are tabulated in Table 2. Both preparations demonstrated endotoxic 
activity. However, gcLPS was 20 fold more potent in the CELD^Q and 
nearly 10 fold more potent in the FI40 than GCE when compared on a weight 
basis. From these results it can be estimated that GCE contained no more 
than 15% LPS. 
Taken as a whole, the results of chemical and biological analyses 
of GCE indicated several things. GCE was mostly protein but there were 
substantial amounts of RNA in some preparations. GCE had endotoxic acti­
vity, but endotoxin was not the major constituent of GCE. These facts 
were taken into account in subsequent experiments which were designed to 
characterize the specific gonococcal antigenic fraction of GCE. 
Ability of GCE to inhibit SAGR 
Previous studies (W. R. Cross and J. A. Rudbach, unpublished data) 
have established that the concentrations of GCE* and anti-gonococcal 
human serum employed in SAGR fell in the equivalence zone or region of 
slight antigen excess. Under these conditions all available antibody 
combining sites are bound by antigen. Addition of non-radioactive GCE, 
therefore, would compete with radiolabeled GCE (GCE*) for antibody com­
bining sites. The ratio of bound-GCE* to unbound-GCE* would be directly 
proportional to the amount of cold GCE added to the reaction mixture. 
It should be emphasized that conditions were established for SAGR so 
that all the human immunoglobulin was precipitated by the addition of 
rabbit anti-human immunoglobulin. It has been shown (19) that if all 
anitbody was precipitated, the fraction of labeled antigen precipiated 
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Table 2. Biological activities of GCE 
and gonococcal LPS. 
FI40* 
CELDisob 
GCE 
3.5 pg 
0.62 yg 
LPS 
0.5 yg 
0.03 yg 
% LPS in GCE 
14.3C 
4.8^ 
&FI40 = yg material required to produce 40 cm^ under 
fever response curve. This was determined as described 
in Materials and Methods. 
''Mean lethal dose (yg) for chick embryos. 
^Calculated by: 
% LPS = 100 X 
^Calculated by: 
% LPS = 100 X 
Flan LPS 
FI40 GCE 
CELD50 LPS 
CELD50 GCEJ 
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would decrease in linear fashion if plotted against the log of the con­
centration of unlabeled inhibitor added. 
Figure 5 shows a series of inhibition curves for a variety of GCE* 
and GCE preparations. In this figure the activity ratios, which are a 
measure of the fraction of GCE* precipitated, are plotted against the 
log of the amount GCE added. There is considerable scattering of points 
and variation from preparation to preparation and assay to assay. In 
order to compare results obtained with different GCE and GCE* prepara­
tions, some means of standardization was needed. The means selected was 
to consider each standard curve separately and express each activity 
ratio as a percent of the activity ratio obtained with the uninhibited 
control for that single experiment. The zero point was defined as the 
lowest activity ratio obtained by inhibition with GCE. This was usually, 
but not always, the activity ratio obtained with 10 wg GCE added as in­
hibitor. Figure 6 shows the same curves from Figure 5 plotted in this 
"normalized" manner. 
The amount of GCE added which gave 50% inhibition of control binding 
was designated the 50% inhibition point, or the IA^Q. The value of the 
IA50 of the standard curves was approximately 1 yg. 
Once it was established that GCE could be used to inhibit SAGR and 
the results were standardized to allow comparisons, treatments could be 
performed on GCE and the effects of these treatments could be measured 
as a change in the capacity of the treated GCE to inhibit SAGR as com­
pared to untreated GCE. In every experiment a standard curve was pre­
pared by assaying untreated GCE. The experimental curve was plotted rel­
ative to the standard curve. The lAgg of each was determined from 
Figure 5. Capacity of GCE to inhibit SAGR. Activity ratios are plotted 
against amount GCE added. Standard curves from 9 different experiments 
shown. Curves with the same symbol represent assays employing the same 
GCE and GCE* preparations. The same standard human positive serum was 
used throughout. 
Activity Ratio 
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Figure 6. Standardization of inhibition curves. Nine inhibition curves 
plotted as a percentage of control binding. Standard curves from 9 dif­
ferent experiments are shown. Curves with the same symbol represent 
assays employing the same GCE and GCE* preparations. The same standard 
human positive serum was used throughout. 
/o of control binding 
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inspection and the activity of the treated GCE was then expressed as a 
percentage of the activity of the untreated GCE. 
Effect of heat treatment on the capacity of GCE to inhibit SAGR 
It is known that most protein antigens are denatured by heating at 
56°C 30 min or by boiling (cf. 1), whereas other antigens such as lipo-
polysaccharides (cf. 48) and glycoproteins (cf. 22) are resistant to heat 
treatment. When GCE was heated at 56®C, 1 h or boiled 2 min there was a 
slight increase or no change in ability to inhibit SAGR. Longer heating 
in a boiling water bath resulted in substantial loss of ability to inhi­
bit SAGR (Figures 7 and 8). The IA.50 values of controls were 1.57 yg to 
1.0 ug; after heating at 56*C for 1 h or boiling 2 min, the IA50 values 
were reduced to 0.2 to 0.7 yg respectively, an increase in activity of 
up to 785% of the control. If GCE was heated in a boiling water bath for 
longer than 2 min, the IA50 increased to 3.3 to 4.0 yg which represented 
a decrease in activity of 70% (Table 3). 
The biphasic nature of the effect of heating was found to be repro­
ducible. It could be that moderate heating caused an increase in solu­
bility or caused some degree of disaggregation of subunits of GCE, 
therefore increasing activity. Prolonged heating at high temperatures 
might have caused denaturation of the antigen. These results were not 
inconsistent with the hypothesis that the specific fraction of GCE was a 
low molecular weight polypeptide. 
Effect of acid and alkali treatment on capacity of GCE to inhibit SAGR 
It was necessary to obtain knowledge of the stability of GCE under 
various conditions of acidity and alkalinity as background information 
Figure 7. Effect of heat treatment on quantitative capacity of GCE to 
inhibit SAGR. Untreated GCE, A; GCE boiled 1 hr, B; GCE heated 56°C, 
1 hr, C. 
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Figure 8. Effect of boiling on quantitative capacity of GCE to inhibit 
SAGR. Untreated GCE, A; GCE boiled 5 ndn, B; GCE boiled 2 min, C. 
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before designing other experiments. Because many of the subsequent pro­
cedures involved incubating GCE at varying pH, it was important to know 
what effects acid and alkali had on GCE so that these effects could be 
taken into account in interpreting other data. 
When GCE was subjected to treatment with 0.1 N HCl for 1 h at 23°C, 
there was a moderate increase in activity (Figure 9), whereas treatment 
with 0.1 N NaOH had a negligible effect in either direction. The IÂ Q 
was reduced from 1.3 yg to 0.48 vg by acid treatment, which calculated 
as an increase in activity to 273% of the control. 
The increase in activity due to acid treatment might be interpreted 
as an indication that more sites had been made available for binding by 
specific antibody. The low pH achieved in this experiment was well below 
the isoelectric point of most proteins (31). At this pH each individual 
molecule has the same net charge. They would, therefore, repel each 
other preventing aggregation (31). Since the preparations were assayed 
immediately following neutralization, it is likely that a larger frac­
tion of subunits of the treated GCE would exist in the disaggregrated 
form than would the subunits of untreated GCE. 
The results of these experiments also showed that GCE was stable to 
treatment with 0.1 N acid or alkali. 
Effect of periodate oxidation on capacity of GCE to inhibit SAGR 
This experiment was designed to determine whether or not a carbo­
hydrate determinant was important for the specific antigenic activity of 
GCE. Periodate is known to cleave sugars between adjacent hydroxyls 
(cf. 5). 
Figure 9. Effect of pH on quantitative capacity of GCE to inhibit SAGR. 
Untreated GCE, A; 0.1 m NaOH treated GCE, B; O.lmHCl treated GCE, C. 
Treatments were for 1 h at 25°C. 
X 
K) 
Ui 
of control binding 
U1 
o N Ui 
O 
o 
T 
C 
CÛ 
o 
b 
o 
UI 
g 
UI 
46 
Oxidation with periodate reduced significantly the capacity of GCE 
to inhibit SAGR (Figure 10). The IAgo was increased from 1.5 yg for un­
treated GCE to 4.0 yg for periodate oxidized GCE (Table 3), a decrease 
in activity to 37.5% of the control. These results showed that GCE was 
sensitive to periodate oxidation. However, it is know that periodate 
can effect some changes in molecules other than sugars (cf. 5). 
Effect of saponification on the capacity of GCE to inhibit SAGR 
If a lipid moiety were important in the specific antigenic activity 
of GCE, this might be detected by a decrease in activity caused by sapon­
ification. KOH in methanol is known to hydrolyze the ester linkage of 
ester-bound fatty acids (22, 31). The fatty acids which are soluble in 
organic solvents would be removed by ether extraction. In this experi­
ment the control was GCE treated with methanol alone and extracted with 
ether. 
There was an increase in activity caused by saponification which is 
not easily explained (Figure 11). The effect was not due to the methanol 
of ether extraction, since the lAgQ of the control was similar to the 
lAgQ of other assays with untreated GCE (Table 3). 
From these results it appeared, however, that there were no fatty 
acid esters essential to the antigenicity of GCE. 
Effect of enzymatic digestion on the capacity of GCE to inhibit SAGR 
The next series of experiments was designed to explore more fully 
the chemical nature of the moieties contributing to the antigenic acti­
vity of GCE. Enzymes specific for different classes of biological 
Figure 10. Effect of periodate oxidation on quantitative capacity of 
GCE to inhibit SAGR. Untreated GCE, A; Periodate oxidized GCE, B. 
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Figure 11. Effect of saponification on quantitative capacity of GCE to 
inhibit SAGR. GCE treated with 0.2 N KOH in methyl alcohol; cleaved 
fatty acids were extracted with ether. Control was GCE treated with 
methanol and extracted with ether. Control, A; Saponified GCE, B. 
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Table 3. Summary of effects of various physical and chemical 
treatments on quantitative capacity of GCE to inhibit SAGR. 
Experiment # Treatment lAsO (Pg)* 
% of standard 
inhibition 
Treated Untreated 
1 0.1 M HCl 0.48 1.30 270.8 
2 0.1 M NaOH 1.40 1.30 92.8 
3 0.2 M KOH-
Methanol 
0.42 1.15 273.8 
4 Periodate 4.00 1.50 37.5 
5 56*C, 1 h 0.20 1.57 785.0 
6 100*C, 1 h 4.00 1.57 39.2 
7 100*C, 2 min 0.70 1.00 142.9 
8 100"C, 5 min 3.30 1.00 30.3 
^lAso = amount GCE required to achieve 50% inhibition of SAGR 
of standard inhibition = lOOX 
lAso untreated GCEl 
IA50 treated GCE J 
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molecules were employed. A series of controls was carried through the 
entire procedure for each assay containing the enzyme, but no GCE. These 
controls (results not shown) indicated that the enzymes alone had no 
effects on SAGR. Proteolytic enzymes were inactivated by boiling for 
2 min following digestion. 
DNase and RNase digestion had little effect on the capacity of GCE 
to inhibit SAGR (Figure 12). However, if the DNase was not inactivated 
before addition of the preparation to the antibody, some inhibition was 
noted (Figure 13). It was felt that this effect might have been due to 
proteases contaminating the crude DNase preparation. It can be seen from 
the summary on Table 4 that the IA50 of both nuclease treated GCE and 
untreated GCE are similar in all cases but one. 
When GCE was digested with a proteolytic enzyme, considerable inac-
tivation was noted. Trypsin-treated GCE was much less able to inhibit 
SAGR than untreated GCE (Figure 14). The lAgg for trypsin treated GCE 
was 3 yg compared with an lAgg of 1.0 yg for untreated GCE, which calcu­
lated a decrease in activity of 67% (Table 4). 
These results showed that GCE was resistant to ribonuclease diges­
tion and deoxyribonuclease digestion, but was sensitive to trypsin 
digestion. 
Effect of enzyme digestion of GCE* on SAGR 
Next to be performed was a direct assay on the susceptibility of 
GCE to enzymatic digestion. It was felt that direct treatment of radio­
labeled GCE (GCE*) might provide results more easily interpretable than 
results from the inhibition assays. An additional set of controls was 
Figure 12. Effect of nuclease digestion on quantitative capacity of 
GCE to inhibit SAGR L. Untreated GCE, A; DNase digested GCE, B; RNase 
digested GCE, C. Enzymes were heat inactivated by boiling 2 min fol­
lowing digestion. 
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Figure 13, Effect of nuclease digestion on quantitative capacity of GCE 
to inhibit SAGR II. Untreated GCE, A; DNase digested GCE, B; RNase di­
gested GCE, C. Enzymes were not inactivated following digestion. 
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Figure 14. Effect of trypsin digestion on quantitative capacity of GCE 
to inhibit SAGR. Untreated GCE, A; trypsin treated GCE, B. 
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Table 4. Summary of effects of enzyme digestion on 
quantitative capacity of GCE to inhibit SAGR. 
Experiment # Treatment IA50 (wg)* 
% of standard 
inhibition^ 
Treated Untreated 
1 DNase 2.1 1.7 81.0 
2 DNase 4.5 2.1 46.7 
3 RNase 2.6 2.1 80.8 
4 RNase 1.5 1.7 113.3 
5 Trypsin 3.0 1.0 33.3 
6 None - 1.0 100.0 
^lAso = amount GCE required to achieve 50% inhibition of SAGR. 
of standard inhibition = 100 X ^^50 untreated GCE 
( IA50 treated GCE 
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included for the proteolytic enzymes in which the GCE* was not added un­
til after heat inactivation of the enzyme. 
When nuclease digestion was carried out on GCE* it was found that 
RNase had little effect, and DNase reduced the activity by 24% (to 76% 
of the control) (Table 5). 
Trypsin and pronase were also employed in the digestion of GCE* 
(Table 5). The activity ratios were significantly reduced by trypsin 
and pronase digestion, to as low as 38.7% of the control. The enzyme 
controls indicated that the heat inactivated proteolytic enzymes re­
tained some capacity to reduce the activity of GCE*. This effect was 
probably due to incomplete inactivation of the enzymes. 
The results of these experiments again showed that GCE* was resis­
tant to nuclease digestion but highly susceptible to digestion by pro­
teolytic enzymes. 
Separation of GCE* components by molecular sieving on SephadexG-200 
This experiment was designed to separate components of GCE on the 
basis of molecular volume. Sephadex G-200 excludes globular molecules 
of molecular weight greater than 800,000 daltons while molecules of lesser 
molecular weight are retained by the gel matrix and their flow through 
the column is impeded. 
Figure 15 shows the results of molecular sieving of GCE* on Sephadex 
G-200. It can be seen from the total radioactivity profile that GCE* was 
separated into 3 major fractions. When the fractions were assayed dir­
ectly in SAGR, it was found that there was a specific activity peak 
coinciding with the peak eluted with the void volume. This suggested 
Figure 15. Separation of GCE components by molecular sieving on 
Sephadex G-200. 
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that the active fraction of GCE existed in a high molecular weight form. 
It was also noted that approximately 30% of the total cpm added to the 
column could not be eluted. 
Fractionation of GCE* by sucrose velocity gradient ultracentrifugation 
Velocity gradient ultracentrifugation is another method of separat­
ing molecules on the basis of size and shape. High molecular weight, 
globular molecules sediment at a greater rate than do low molecular weight 
molecules. A 20 yg sample of GCE* was centrifuged at 100,000 x £ for 16 h 
on a discontinuous gradient of 10% to 50% sucrose. 
Figure 16 depicts the results of fractionation of GCE* by sucrose 
velocity gradient ultracentrifugation. Although little separation was 
detected in the total cpm profile, when the fractions were assayed by 
SAGR, two areas of high antigenic reactivity were found, one at each 
extreme of the gradient. This suggested either that the active fraction 
of GCE existed in an aggregated, high molecular weight form and as low 
molecular weight subunites, or that there were two distinct, active frac­
tions, one of high molecular weight and one of low molecular weight. 
Comparison of the capacities of GCE and gcLPS to inhibit SAGR 
The biological studies previously described in this paper showed 
that GCE contained no more than 10% LPS. It was possible that this small 
LPS component was responsible for the specific activity of GCE. If this 
were the case then purified gonococcal LPS would be able to inhibit SAGR 
to a greater extent than could GCE. The following experiment was de­
signed to test this possibility. 
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Figure 17 shows inhibition curves for GCE and gcLPS. The IA50 for 
each is shown in Table 6. The lAgg for the LPS preparation was 10 fold 
greater than the lAgg of GCE. If the major antigenic component of GCE 
were LPS, it would be expected that the LPS preparation would have approx­
imately a 10 fold lower lAgg than GCE. Since the reverse was true, it 
could be assumed that the antigenic component specific for the gonococcus 
in GCE was not LPS. 
Comparison of the capacities of "T1 phase" GCE and "T3 phase" GCE 
to inhibit SAGR 
The following experiments were designed to investigate whether or 
not the specific fraction of GCE was unique to virulent phases of gono-
cocci. Four colony types of N. gonorrhoeae have been described by 
Kellogg, et ai. (28). Two types (T1 and T2) are virulent and two types 
(T3 and T4) are avirulent (28). The most obvious difference among the 
bacteria contained in these different types of colonies is that colony 
types T1 and T2 contain piliated organisms whereas colony types T3 and T4 
contain nonpiliated organisms (25, 52, 60). These characteristics were 
confirmed by electron microscopy (Figure 18) for the organisms used in 
this study. 
GCE from T1 phase gonococci and GCE from T3 phase gonococci (T3-GCE) 
were compared in their ability to inhibit SAGR. The results of inhibi­
tion studies are shown in Figure 19 and Table 6. The lAgQ of T3-GCE was 
10.0 yg compared to 0.46 yg for GCE. The activity of T3-GCE was only 5% 
of the activity of GCE. These results indicated that the specific com­
ponent of GCE was not found in T3 phase gonococci and was, therefore, 
probably associated with virulent gonococci. 
Figure 16. Separation of GCE components by sucrose density gradient 
ultracentrifugation. 
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Figure 17. Comparison of capacities of GCE and gcLPS extract of T1 
phase gonococci to quantitatively inhibit SAGR. GCE, A; gcLPS, B. 
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Figure 18. Electron micrographs of gonococci from T1 and T3 colony 
types. Plates A and B show gonococci from T1 colonies; note presence 
of pili. X 24,000. Plate C shows gonococci from a T3 colony; note 
absence of pili. X 24,000. 
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Figure 19. Comparison of T1 phase GCE with T3 phase GCE on quantita­
tive capacity to inhibit SAGR. T1 phase GCE, A; T3 phase GCE, B. 
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Table 5. Siamnary of effects of enzyme digestion of GCE*& on SAGR. 
Experiment # Treatment Activity ratio^ % of control*' 
Treated Untreated 
1 DNase 0.633 0.831 76.2 
2 DNase 0.633 0.819 77.3 
3 RNase 0.792 0.762 103.9 
4 RNase 0.789 0.880 89.7 
5 Trypsin 9.318 0.822 38.7 
6 Trypsin control ̂ 0.628 0.822 76.4 
7 Pronase 0.328 0.822 39.9 
8 Pronase control^ 0.656 0.822 79.8 
9 None 0.822 100.0 
accE* = 125i labelled GCE. 
^Activity ratio = cpm in ppt - background (BKG) cpm 
cpm in ppt - cpm BKG + cpm in 100 yl SF - cpm BKG 
H of control = 100 X 
^Trypsin and pronase control: Enzymes incubated in saline followed 
by boiling 2 min prior to addition of GCE*. 
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Table 6. Comparative ability of GCE, T3 Phase GCE, 
and gcLPS extract of T1 Phase gonococci to 
quantitatively inhibit SAGR. 
inhibitor tested IA50 W* relative activity^ 
gcLPS 6.00 10.8 
GCE 0.65 100.0 
"T3 Phase" GCE 10.00 4.6 
GCE 0.46 100.0 
^lAgQ - amount of extract required to achieve 50% inhibition 
of SAGR. 
, ( lAso GCE I 
^Relative activity = 100 X [ia^q sample] 
CHAPTER IV 
DISCUSSION 
In this study an antigen, specific for Neisseria gonorrhoeae which 
was contained in a crude gonococcal extract, was characterized by a 
variety of techniques. The crude extract was found to contain mostly 
protein and substantial amounts of RNA in some preparations. The ex­
tract was toxic for chick embryos and caused febrile responses in rabbits. 
These biological activities were typical of those of purified endotoxin 
preparations. However, on a weight to weight conçarison, GCE had not 
more than 15% of the biological activity of purified gonococcal endo­
toxin. The specific gonococcal fraction of GCE was consistent with the 
properties of a low molecular weight glycoprotein. These low molecular 
weight molecules could have aggregated spontaneously to form large com­
plexes with molecular weights of 800,000 daltons or more. 
The original objectives of this study were to characterize a gono­
coccal specific antigen which was contained in a crude gonococcal extract. 
The crude extract, containing a mixture of antigens currently is employed 
in a radioimmunoassay for the quantification of anti-gonococcal activity 
of human serum (36). It was hypothesized, based on the extraction pro­
cedure and previous work (Rudbach, unpublished data), that the specific 
fraction of GCE was a protoplasmic polypeptide, glycoprotein, or nucleo-
protein. The possibility existed, however, that other cell components. 
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such as endotoxin or pili, were important in the specific anti-gonococcal 
reaction (SAGR). 
Two general approaches were used in characterizing the antigen. 
In the first approach chemical analyses were performed for protein, DNA, 
and RNA; endotoxic activity was determined, and molecular size was esti­
mated. In the second approach GCE was treated by a variety of methods 
designed to destroy or alter specific materials. GCE so treated was then 
analyzed for capacity to inhibit SAGR. By this means it was hoped to 
characterize the specific gonococcal fraction of GCE with respect to 
activity in SAGR. Any treatment which denatured or destroyed the gono­
coccal specific fraction of GCE would result in an increase in the amount 
of antigen required to inhibit by 50% the binding of GCE* with the spe­
cific antibody. Conversely, any treatment that increased solubility or 
exposed more antigenic determinants would result in a decrease in the 
amount of antigen required for 50% inhibition, reflecting an increase in 
the capactiy of the treated GCE to inhibit SAGR. 
Chemical and biological properties of GCE and their relationship to 
specific gonococcal antigenic activity 
A first step in the process of characterizing the gonococcal speci­
fic antigen was to learn something of the overall chemical composition 
of GCE. This could indicate the direction subsequent investigation 
should take. By direct chemical analysis it was found that GCE was most­
ly protein, but that there were amounts of RNA of up to 34% in some pre­
parations. DNA was found to account for less than 1% of the weight of 
GCE. These were the only chemical analyses performed because of the 
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small amounts of GCE available. The results of chemical analyses sug­
gested that the gonococcal specific fraction of GCE could be a protein 
or a nucleoprotein. Although direct analyses for carbohydrate and ester-
bound lipid content were not performed, the contribution of these mater­
ials to the gonococcal specific antigen was investigated in later exper­
iments . 
A variety of evidence suggested that the protein component of GCE 
was important for the gonococcal specific antigenicity of GCE. It was 
found that the capacity of GCE to inhibit SAGR was greatly reduced when 
GCE was digested with either pronase or trypsin. Becasue the capacity 
of GCE to inhibit SAGR was destroyed when the protein component of GCE 
was destroyed, it was concluded that a protein moiety was part of the 
gonococcal specific antigen. In order to add confidence to this inter­
pretation, radio-labeled GCE (GCE*) was treated directly With proteolytic 
enzymes. When the protein component of labeled GCE was destroyed by 
digestion with proteolytic enzymes there was a great loss in antigenic 
activity as indicated by a marked reduction in its binding with anti­
bodies in the standard anti-gonococcal human serum. From these results 
it was confirmed that a protein moiety was essential to the antigenicicy 
of GCE. 
Because several GCE preparations contained appreciable amounts of 
RNA, it was of interest to investigate the possible role of nucleic 
acids in the gonococcal specific antigenic activity of GCE. It was found 
that GCE retained nearly full capacity to inhibit SAGR following incuba­
tion of GCE with RNase or DNase. These results suggested that nucleic 
acids were not essential for the gonococcal specific antigenic activity 
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of GCE. In order to add confidence to the interpretation of these re­
sults, as was done previously with proteolytic enzymes, radio-labeled 
GCE was itself incubated with nucleases. GCE* so treated retained most 
of its origianl specific gonococcal antigenic activity as shown by no 
decrease, or only a slight decrease, in binding activity. It was con­
cluded on the basis of these results that a nucleic acid component was 
not essential to the gonococcal specific antigenic activity of GCE. 
In addition to the experiments in which enzymatic treatments were 
used to analyze the contributions of protein and nucleic acid components 
to the gonococcal specific antigenic activity of GCE, other treatments 
of GCE were performed to investigate contributions made by putative 
carbohydrate or lipid components of GCE. The possibility that carbohy­
drate was part of the specific immunodeterminant group of GCE was inves­
tigated by subjecting GCE to oxidation by periodate. It was found that 
GCE so treated lost much of its capacity to inhibit SAGR. Although other 
reactions might have taken place, these data were interpreted as indi­
cating that destruction of carbohydrate component reduced the gonococcal 
specific antigenic activity of GCE. 
The possible role of an ester-bound lipid component was investigated 
by subjecting GCE to saponification with KOH in methanol. It was found 
that following saponification, the capacity of GCE to inhibit SAGR in­
creased slightly. These results showed that no ester-bound lipid was 
essential to the gonococcal specific antigenic activity of GCE. 
The experiments discussed to this point were designed to investigate 
contributions to the gonococcal specific antigenic activity of GCE made 
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by specific classes of biological molecules. It was hypothesized that 
neither a lipid nor a nucleic acid component was essential. Of the 
classes of bio-molecules studied only a protein and a carbohydrate com­
ponent were found to be important to the gonococcal specific antigenic 
activity of GCE. These results suggested that the gonococcal specific 
antigenic fraction of GCE was a glycoprotein. 
The following experiments represented a change in direction of the 
approach to characterization of the gonococcal specific fraction of GCE. 
In these experiments the relationship between GCE and two known gono­
coccal components was studied. Gonococcal endotoxin (LPS) and pili have 
received considerable attention from other researchers (8, 17, 38-46, 52, 
61) investigating the antigenicity of the gonococcus, and it was necessary 
to determine the relationship of GCE to these components. 
Endotoxin, which is a cell wall conçionent of gram negative bacteria, 
has been shown to be defined best by its biological activities (48). Two 
biological properties of endotoxin are its toxicity for chick embryos 
(15, 16, 59) and its abiltiy to produce a febrile response in rabbits 
(47, 67). GCE was compared to a preparation of purified gonococcal LPS 
by these two assays. It was found that on a weight to weight comparison, 
GCE had not more than 15% of the biological activity of the purified endo­
toxin. These results were interpreted to indicate that endotoxin represented 
15% by weight of the total composition of GCE. If this endotoxic com­
ponent were in fact the gonococcal specific fraction of GCE then purified 
gonococcal endotoxin would be expected to have nearly a 10 fold greater 
capacity than GCE to inhibit SAGR. However, when GCE and gonococcal 
endotoxin were compared in their capacities to inhibit SAGR, it was found 
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that endotoxin had only one tenth of the capacity of GCE to inhibit SAGR. 
It was, therefore, concluded that the specific fraction of GCE was not 
represented by an antigenic determinant of gonococcal endotoxin. 
It has been shown that colonial morphology of cultures of N. gonor­
rhoeae could be correlated with virulence (28). One physical character­
istic that differentiates cells from virulent colony types from cells 
from avirulent colony types is that virulent cells possess pili (25, 60). 
In addition, a number of cytoplasmic factors have been described in cells 
from other colony types (11, 51). It was of interest to investigate the 
relationship between these "virulence factors" and the gonococcal specific 
fraction of GCE. 
In order to determine if the gonococcal specific antigen was found 
only in virulent cells, an extract of cells from a colony type represen­
tative of avirulent gonococci was compared with GCE (which was prepared 
from virulent cells). The avirulent cells were shown by electron-
microscopy to lack pili. The extract of these cells was designated 
T3GCE. It was found that T3GCE had less of a capacity to inhibit SAGR 
than did GCE. This suggested that the gonococcal specific antigen might 
be virulence associated. 
The fact that the gonococcal specific antigen was associated with 
virulent cells raised the possibility that the antigen was in fact pili 
or the subunit, pilin. The only evidence obtained relevant to this point 
was ultra violet absorption data for GCE. GCE was found to have a UV 
absorption peak only at 260 nm. It is not known if gonococcal pili have 
UV absorption spectra identical to & coli type I pili from Escherielia 
coli; however, Brinton (6, 7) has shown that the latter have UV absorption 
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peaks at 280 and 285 nm. The difference in absorption spectra between 
GCE and coli pili was considered evidence that pili or pilin were not 
a major component of GCE. 
Physical properties of GCE and their relationship to specific 
gonococcal antigenic activity 
From the experiments discussed previously it was shown that the 
gonococcal specific fraction of GCE was probably a glycoprotein assoc­
iated with cells of virulent colony types. The experiments discussed in 
this section were designed to investigate the molecular size and shape, 
the state of aggregation or disaggregation, and other physical properties 
of the gonococcal specific antigenic fraction of GCE. 
The heat stability of GCE was one of the first properties investi­
gated. It was found that the capacity of GCE to inhibit SAGR was not 
reduced by heat treatments of 56"C for 30 min or boiling for 2 min. In 
several instances, in fact, the capacity of GCE to inhibit SAGR was in­
creased by these treatments. However, if GCE was boiled for longer than 
2 min, the capacity to inhibit SAGR was reduced greatly. Denaturation 
of protein antigens is thought to destroy antigenic specificity by caus­
ing unfolding of the peptide chain (cf. 1). The moderate heat stability 
of GCE was, therefore, considered evidence that the gonococcal specific 
antigen, already thought to be a glycoprotein, was a small, linear or 
loosely folded molecule, the antigenic specificity of which would not be 
altered by further unfolding. If aggregates of the specific antigen 
formed, moderate heating could have disrupted such aggregates, thereby 
exposing more antigenic determinants. This could explain the increased 
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capacity of GCE to inhibit SAGR after GCE was subjected to moderate heat­
ing. The fact that prolonged boiling of GCE reduced its capacity to in­
hibit SAGR was consistent with the notion that the gonococcal specific 
antigen had an essential protein moiety. Prolonged boiling would be 
expected to cause coagulation and loss of solubility of the antigen 
(cf. 1) thereby decreasing the capacity of GCE to inhibit SAGR. 
GCE was also tested for stability to treatment with acid and alkali. 
When GCE was treated with 0.1 N NaOH for 1 h there was no loss of capa­
city to inhibit SAGR. Treatment with 0.1 N HCl resulted in a slight in­
crease in the capacity of GCE to inhibit SAGR. Acid conditions have 
been shown to increase the solubility of many proteins (cf. 31). Acid 
treatment could have, again, disrupted aggregates of a small glycoprotein 
by increasing the solubility of the subunits. More antigenic determin­
ants could have become available for antibody binding thereby increasing 
the capacity of a given amount of GCE to inhibit SAGR. The results of 
these experiments are consistent with the hypothesis that the gonococcal 
specific antigen was a small glycoprotein. 
More direct evidence of the size and shape of the gonococcal spec­
ific antigen was obtained when GCE was subjected to fractionation by gel 
filtration and density gradient ultracentrifugation. GCE was separated 
into 3 major fractions by molecular sieving on Sephadex G-200. The gono­
coccal specific portion of GCE was eluted in the void volume. Sephadex 
G-200 gel excludes molecules of molecular weight greater than 800,000 
daltons. It was concluded, therefore, that the specific fraction of GCE 
exists in a form with a molecular weight equal to or greater than 
800,000. It was noted that approximately 30% of the total radioactivity 
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added to the column was not eluted which suggested that some fraction of 
GCE binds Sephadex or was otherwise trapped in the gel matrix. 
When GCE was fractionated by ultracentrifugation on a gradient of 
10% to 50% sucrose, two peaks of high activity were found, one at each 
extreme of the gradient. This suggested either that the specific frac­
tion of GCE existed in an aggregated, high molecular weight form and as 
low molecular weight subunits, or that there were two distinct, specific 
fractions, one of high molecular weight and one of low molecular weight. 
It was thought that the portion of GCE not eluted from the Sephadex 
column might correspond to the low molecular weight fraction from the 
sucrose gradient. In velocity gradient ultracentrifugation molecules 
sediment at a rate proportional to their size (31). However, a molecule, 
even of macromolecular dimensions, that had a density less than that of 
10% sucrose would not penetrate the gradient. Lipids are the most 
likely class of bio-molecules to have such low density. It was possible, 
therefore, that the non-sedimenting fraction of high gonococcal specific 
activity represented a lipid moiety. However, the fact that the activity 
of GCE was not reduced by saponification showed that an esterified lipid 
was not essential for the specific antigenicity of GCE. Therefore, the 
non-sedimenting fraction of high gonococcal specific antigenic activity 
most probably represented a low molecular weight moiety. 
A model for the structure or GCE 
This study has shown that GCE is a heterogeneous mixture of cellu­
lar components containing at least one moiety that is antigenically 
specific for the gonococcus. Fractionation by molecular sieving and 
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velocity gradient untracentrifugation showed that while GCE contained a 
wide range of molecular sized, the specific activity was found in only 
a small portion of the total. Many of the problems encountered in es­
tablishing the inhibition assay and in interpreting results may have been 
attributable to effects of these antigenically non-specific materials. 
Because much of the specific antigenic activity of GCE was destroyed 
by digestion with proteolytic enzymes and by oxidation with periodate, 
it was felt that the gonococcal specific antigen was a glycoprotein. It 
was thought that the specific antigen was a large molecule because the 
high activity fraction of GCE was eluted in the exclusion volume from 
Sephadex G-200. Other evidence, such as heat stability and position on 
sucrose velocity gradient untracentrifugation, however, suggested that 
the gonococcal specific antigen could exist as a small molecule and that 
the high molecular weight fraction represented an aggregation of these 
small glycopeptides. 
Moderate heat treatment, treatment with mild acid, and saponifica­
tion are treatments that would be expected to disrupt aggregates of 
glycopeptides. One effect of disrupting an aggregate of antigenic mole­
cules would be to expose more antigenic determinants which would result 
in an increase in reactivity of the antigen with antibodies. That these 
treatments did, in fact, increase this activity of GCE indicated that 
the gonococcal specific antigen formed large aggregates spontaneously. 
This view was supported by the demonstration of a fraction with high gono­
coccal specific antigenic activity in the upper layers of the sucrose 
velocity gradient untracentrifuge tube. 
A schematic representation of the hypothetical structure of the 
gonococcal specific antigen is shown in Figure 20. 
Figure 20. Schematic model of the structure of the gonococcal specific 
antigen. The polypeptide component of the antigen is indicated by solid 
black lines; the carbohydrate component is indicated by solid black 
circles. Integral to this model is the ability of the monomers to spon­
taneously aggregate into micellar bundles. 
Monomers Aggregate 
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Relationship of GCE to other known gonococcal antigens 
Because there already was much known about antigens of the gono-
cocus it was of interest to compare the properties of GCE with the 
properties of antigens reported by others. Antigens reported by others 
include cell wall extracts (17, 38-46, 61), pili (8, 52), and proto­
plasmic antigens (2, 3, 11, 13, 29, 30, 51, 54, 58). GCE was found to 
share some characteristics with some of these antigens. However, because 
characterization of these antigens and GCE has been incomplete, the 
exact relationship between GCE and other reported antigens could not be 
determined precisely. 
Maeland (39-41) has extracted gonococcal endotoxin with phenol-water 
and aqueous ether. He found two antigenic determinants designated a and 
3. Determinant a was found to be a polysaccharide reactive in complement 
fixation tests (39). This antigen showed some degree of specificity 
for N. gonorrhoeae. The 3 determinant was proteinaceous in nature and 
also reacted in complement fixation tests but was found to cross react 
extensively with other Neisseria species (39). The 3 determinant has 
been characterized further as an acidic glycoprotein (3). Because endo­
toxin was found to have no importance in the specificy of GCE, there is 
probably little relationship between these antigens and GCE. 
Buchanan et al. (8) have worked with gonococcal pili in a radioim­
munoassay for the detection of antibodies against pili antigens in sera 
of human patients. They have demonstrated considerable serological 
specificity with this assay. Recently, Novotny and Turner (50) have 
shown that the antigens of gonococcal pili are highly strain (sic) spec­
ific. They investigated 31 strains of N. gonorrhoeae by gel diffusion 
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against antisera raised against pili of 3 strains. They found few reac­
tions of identity between strains. These results cast some doubt on the 
usefulness of gonococcal pili as diagnostic antigens. 
Although the presence of pili on the cell surface has been shown to 
be the major morphological feature distinguishing virulent gonococci 
from avirulent gonococci (25, 60), pili are not the only distinguishing 
feature. Cheng et al. (11) have isolated from protoplasm of cells from 
colony type T1 a toxic, heat labile polypeptide, designated B, that was 
not found in protoplasm of cells from colony type T3 of the homolgous 
isolate. Also, Pierce et al. (51) isolated a polypeptide unique to 
virulent cells that was shown by gel diffusion to be distinct from LPS, 
pili, and the B antigen described by Cheng. This polypeptide was desig­
nated Ag-1. Both the B antigen and Ag-1 were eluted in the exclusion 
volume from Sephadex G-200, and both were destroyed by proteolytic en­
zymes (11, 51). The active fraction of GCE appears to be similar to 
Ag-1 and the B antigen in as much as all are eluted in the exclusion 
volume from Sephadex G-200, all are destroyed by proteolytic anzymes, 
and all are associated with cells from T1 colony types. Also, GCE pos­
sessed toxicity for chick embryos similar to that of the B antigen. 
Toxicity of Ag-1 was not determined (51). However, the active fraction 
of GCE could not be identified completely with Ag-1 or the B antigen at 
this time. 
Another antigen that may bear some relation to GCE was character­
ized by Danielsson et al. (13). They passed gonococcal protoplasm through 
Sephadex G-200 and found a component in the first half of the first elu-
tion peak that reacted in complement fixation tests with sera of 20% of 
males and 73% of females who were culturally positive for N. gonorrhoeae. 
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No positive reactions were found in negative controls (54). Because this 
antigen was not characterized biochemically its relationship to the speci­
fic fraction of GCE cannot be determined. 
Gonococcal ribosomes have been used with promising results as skin 
test antigens in guinea pigs (26). However, studies employing hyperim-
muni zed animals have been of questionable value when applied to the human 
system because of the minimal immunological response elicited by the 
natural infection in humans. However, in other systems (cf. 26) ribo­
somes have proved to provide highly specific antigens. Also, some pre­
parations of GCE did have a high RNA content. Therefore, the possibility 
that gonococcal ribosomes had a role in the antigenicity of GCE was con­
sidered. It was found that treatment with RNase had no effect on the 
specific activity of GCE which suggested that intact ribosomes were not 
essential for the antigenicity of GCE. However, the possibility that the 
specific gonococcal fraction of GCE was a ribosomal protein could not be 
excluded. 
Much more work remains to be done before the specific antigens of 
the gonococcus will be fully characterized. This study has contributed 
to that process and information was obtained which will help to refine 
an assay for the detection of gonococcal specific antibodies in human 
sera. 
CHAPTER V 
SUMMARY 
An antigen specific for Neisseria gonorrhoeae contained in an ethanol 
precipitate of a surfactant extract of T1 phase gonococci was character­
ized by a variety of techniques. A limited chemical analysis indicated 
that the crude extract (GCE) was mostly protein but that some preparations 
contained up to 37% RNA. The extract was biologically active, in that it 
had 1/20 and 1/7 the potency of purified gonococcal LPS in assays of chick 
embryo lethality and pyrogenicity in rabbits, respectively. 
The major portion of the project was devoted to investigating the 
chemical, physical, and biological properties of GCE and their relation 
to specific gonococcal antigenic activity. The model system employed 
human sera from patients naturally infected with N. gonorrhoeae. Gono­
coccal specific antibodies in the human serum were detactable with a radio­
immunoassay employing labeled GCE (GCE*). This specific antigono­
coccal reaction (SAGR) could be inhibited by the addition of cold GCE. 
Many properties of the gonococcal specific antigen were investigated by 
subjecting cold GCE to various treatments and then assaying this treated 
GCE for capacity to inhibit SAGR. It was found that gonococcal specific 
antigenic activity was increased by the following treatments: 1) heating 
at 56'C, 1 h; 2) treatment with 0.1 N HCl, 30 min, 25°C; 3) saponification 
by 0.1 N KOH in methanol. Gonococcal specific antigenic activity was de­
creased by the following treatments: 1) heating 5 min in a boiling water 
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bath; 2) oxidation by periodate; 3) enzymatic digestion with trypsin or 
pronase. It was found that gonococcal specific antigenic activity was 
unaffected by the following treatmens: 1) heating 2 min in a boiling 
water bath; 2) treatment with 0.1 N NaOH, 30 min, 25°C; 3) enzymatic diges­
tion with DNase or RNase. It was found that a GCE preparation from non-
pi liated gonococci of T3 phase colony types lacked the gonococcal specific 
antigenic activity exhibited by GCE preparations from piliated bacteria 
of T1 phase colonies. It was also found that gonococcal LPS lacked the 
gonococcal specific antigenic activity exhibited by GCE. 
The molecular size of the gonococcal specific antigen was investi­
gated by fractionating labeled GCE by molecular sieving on Sephadex G-200 
and by velocity gradient ultracentrifugation. Results of both fractiona­
tion methods revealed that gonococcal specific antigenic activity was 
contained in a high molecular weight fraction. In addition, a low mole­
cular weight fraction exhibiting gonococcal specific antigenic activity 
was recovered from the top of the sucrose gradient. 
A model for the structure of the gonococcal specific antigen was 
proposed to account for the above findings. It was hypothesized that the 
gonococcal specific antigen was a low molecular weight, linear or loosely 
folded, glycoprotein. Large, apparently stable, aggregates appeared to 
occur spontaneously. 
LITERATURE CITED 
1. Abramoff, P. and M. F. LaVia. 1970. Biology of the immune response. 
McGraw-Hill Book Company, New York, NY. 
2. Apicella, M. A. 1974. Antigenically distinct populations of Neisseria 
gonorrhoeae : isolation and characterization of the responsible 
determinants. J. Infect. Dis. 130:619-625. 
3. Apicella, M. A. and J. C. Allen. 1973. Isolation and characterization 
of the B antigen of Neisseria gonorrhoeae. Infect. Immun. 7^:315-321. 
4. Ashton, F. E., R. Wallace, and B. B. Diena. 1974. Serum- mediated pro­
tection of microtissue cultures against gonococcal infection. Can. 
J. Microbiol. 1423-1425. 
5. Biochemists Handbook. 1961. C. Long (ed). D. Van Nostrand Company, 
Inc. Princeton, NJ. 
6. Brinton, C. C. Jr. 1967. Contributions of pili to the specificity of 
the bacterial surface, and a unitary hypothesis of conjugal in­
fectious heredity, p. 37-70. In B. D. Davis and L. Warren (eds), 
The specificity of cell surfaces. Prentice-Hall, Inc. 
7. Brinton, C. C. Jr. 1969. The structure, function, synthesis and genetic 
control of bacterial pili and a molecular model for DNA and RNA 
transfer in gram negative bacteria. Trans. N. Y. Acad. Sci. 27: 
1003-1054. 
8. Buchanan, T. M., J. Swanson, K. K. Holmes, S. J. Kraus, and 
E. C. Gotschlich. 1973. Quantitative determination of antibody 
to gonococcal pili. Changes in antibody levels with gonococcal 
infection. J. Clin. Invest. 52:2896-2909. 
9. CDC Weekly Report: Cases of specified notifiable diseases: United 
States. 1973. Morbidity mortality weekly rep. 22:225. 
10. Chacko, C. W. and G. M. Nais. 1969. Sero-diagnosis of gonorrhea with 
a microprecipitin test using a lipopolysaccharide antigen from 
N. gonorrhoeae. Brit. J. Ven. Dis. 45:33-39. 
11. Cheng, A., J. B. G. Kwapinski, and A. R. Ronald. 1974. Isolation and 
immunological characterization of a unique toxic cytoplasmic 
polymer of type 1 Neisseria gonorrhoeae. Can J. Microbiol. 20: 
1163-1167. 
92 
93 
12. Danielsson, D. G. and G. Kronvall. 1974. Slide agglutination method 
for the serological identification of Neisseria gonorrhoeae with 
anti-gonococcal antibodies adsorbed to protein A containing Staph­
ylococci. Appl. Microbiol. 27:368-374. 
13. Danielsson, D. G., J. D. Schmale, W. L. Peacock, Jr., and J. D. Thayer. 
1969. Antigens of Neisseria gonorrhoeae: Characterization by gel 
filtration, complement fixation and agar-gel diffusion of anti­
gens of gonococcal protoplasm. J. Bacteriol. 97:1012-1017. 
14. Enfors, W., G. Eriksson, J. Kaaman, and G. von Krogh. 1973. Neisseria 
gonorrhoeae indentified by the direct fluorescent antibody tech­
nique in male contacts. Brit. J. Ven. Dis. 49:500-504. 
15. Finkelstein, R. A. and G. M. Ramm. 1962. Effect of age on suscepti­
bility to experimental cholera in embryonated eggs. J. Infect. Dis. 
111:239-249. 
16. Finkelstein, R. A. 1964. Observations on mode of action of endotoxin 
in chick embryos. Proc. Soc. Exp. Biol. Med. 115:702-706. 
17. Fletcher, S., R. Miller, and C. S. Nicol. 1973. Study of a passive 
haemagglutination test for gonorrhoea. Brit. J. Ven. Dis. 49: 
508-510. 
18. Gaafar, H. A. and D. D*Archangelis. 1972. Sero-diagnosis of gonorrhea 
by immuno fluorescent technique. Annual Meeting of the American 
Society of Microbiology. 114 (Abstract). 
19. Gander, J. E. and J. A. Rudbach. 1972. Immunological investigations of 
pénicillium—II. Primary binding of glycopeptides and glycopeptide 
derivatives to specific antibodies. Immunochem. 10:81-92. 
20. Gruber, J. and G. C. Wright. 1967. Iodine 131 labeling of purified 
microbial antigens by microdiffusion. Proc. Soc. Exp. Biol. Med. 
126:282-284. 
21. Mansfield, H. H., T. 0. Lipman, J. P. Hamish, E. Tronca, and 
K. K. Holmes. 1974. Asymptomatic gonorrhea in men. New Engl. J. 
Med. 290:117-123. 
22. Hawk, P. B., B. L. Oser, and W. H. Summerson. 1954. Practical physio­
logical chemistry. 13th edition. McGraw-Hill Book Company, New York, 
NY. 
23. Holmes, K. K. 1973. Gonococcal infection: Clinical epidemiologic, and 
laboratory perspectives, pp. 259-285. In Advances in Internal 
Medicine. Vol. 19. Academic Press, New York, NY. 
24. Irwin. J. 0. and E. A. Cheeseman. 1939. On an approximate method of 
determining the median effective dose and its error, in the case 
of a quantal response. J. Hyg. 39:574-580. 
94 
25. Jephcott, A. E., A. Reyn, A. Birch-Andersen. 1971. Neisseria gonorrhoeae. 
III. Demonstration of presumed appendages to cells from different 
colony types. Acta Path. Microbiol. Scand. Sect B. 79:457-439. 
25a. Johnson, M. J. 1941. Isolation and properties of a pure yeast polypep­
tidase. J. Biol. Chem. 137:575-586. 
26. Judd, R. C. 1974. Gonococcal ribosomes as skin test antigens. Masters 
Thesis. University of Montana, Missoula, MT. 
27. Kabat, E. A. and M. M. Mayer. 1968. Experimental Immunochemistry, 
second edition. Charles C Thomas. Springfield, IL. 
28. Kellogg, D. S., I. Cohen, L. Norins, A. Schroeter, and G. Reising. 
1968. Neisseria gonorrhoeae clonal variation and pathogenicity 
during 35 months in vitro. J. Bacteriol. 96:596-605. 
29. Kwapinski, J. B. G. and A. Cheng. 1974. Preliminary observations on 
the protective action of a cytoplasmic immunogen of Neisseria 
gonorrhoeae. Can. J. Microbiol. 20:332-337. 
30. Lee, L. and J. D. Schmale. 1970. Identification of a gonococcal antigen 
important in the human immune response. Infect. Immun. 1^:207-208. 
31. Lehninger. A. L. 1970. Biochemistry. Worth Publishers, Inc. New York, NY. 
32. Lind, I. 1969. Combined use of flqorescent antibody technique and cul­
ture on selective medium for the identification of Neisserea 
gonorrhoeae. Acta Path. Microbiol. Scand. 76:279-287. 
33. Logan, L. C., P. M. Cox, L. C. Norins. 1970. Reactivity of two gono­
coccal antigens in an automated microhemagglutination procedure. 
Appl. Microbiol. 20:907-909. 
34. Lucas. C. T., F. Chandler, Jr., J. E. Martin, Jr., J. D. Schmale. 1971. 
Transfer of gonococcal urethritis from man to chimpanzee. An animal 
model for gonorrhoea. J. Am. Med. Assoc. 216:1612-1614. 
35. Lucus, J. B., E. V. Price, J. D. Thayer, A. Schroeter. 1967. Diagnosis 
and treatment of gonorrhea in the female. New Engl. J. Med. 276: 
1454-1459. 
36. Luoma, M. K., W. R. Cross, and J. A. Rudbach. 1975. Radioimmunoassay 
for quantifying antibody to Neisseria gonorrhoeae in human sera. 
Brit. J. Ven. Dis. 5^:387-391. 
37. Maeland, J. A. 1966. Antibodies in human sera against antigens in gono-
cocci, demonstrated by a passive haemolysis test. Acta Path. 
Microbiol. Scand. 67:102-110. 
38. Maeland, J. A. 1968. Antigenic properties of various preparations of 
Neisseria gonorrhoeae endotoxin. Acta Path. Microbiol. Scand. 
73:413-422. 
95 
39. Maeland, J. A. 1969. Antigenic determinants of aqueous ether extracted 
endotoxin from Neisseria gonorrhoeae. Acta Path. Microbiol. Scand. 
76:475-483. 
40. Maeland, J. A. 1969. Immunochemical characterization of aqueous ether 
extracted endotoxin from Neisseria gonorrhoeae. Acta Path. Micro-
bil. Scand. 76:484-492. 
41. Maeland, J. A. 1969. Serological properties of aqueous ether extracted 
endotoxin from Neisseria gonorrhoeae. Acta Path. Microbiol. Scand. 
77:495-504. 
42. Maeland, J. A. 1969. Serological cross-reactions of aqueous ether ex­
tracted endotoxin from Neisseria gonorrhoeae. Acta Path. Microbiol. 
Scand. 77:505-517. 
43. Maeland, J. A. and T. Kristofferson. 1971. Immunochemical investigations 
on Neisseria gonorrhoeae endotoxin. I. Characterization of phenol-
water extracted endotoxin and comparisons with aqueous ether pre­
parations. Acta Path. Microbiol. Scand. Sect. B. 79:226-232. 
44. Maeland, J. A., T. Kristofferson, and T. Hofstad. 1971. Immunochemical 
investigations on Neisseria gonorrhoeae endotoxin. 2. Serological 
multispecificity and other properties of phenol-water preparations. 
Acta Path. Microbiol. Scand. Sect. B 79:233-238. 
45. Maeland, J. A., F. Wesenberg, and 0. Tonder. 1973. Modified erythrocytes 
in indirect haemagglutination with Neisseria gonorrhoeae antigen. 
Brit. J. Ven. Dis. 49:256-259. 
46. Martin, J. E., Jr., W. L. Peacock, Jr., G. Reising, D. S. Kellogg, Jr., 
E. Ribi, and J. D. Thayer. 1969. Preparation of cell walls and 
protoplasm of Neisseria with the Ribi cell fractionator. J. Bac-
teriol. 97:1009-1011. 
47. Milner, K. C., R. A. Finkelstein. 1966. Bioassay of endotoxin: correla­
tion between pyrogenicity for rabbits and lethality for chick 
embryos. J. Infec. Dis. 116:529-536. 
48. Milner, K. C., J. A. Rudbach, and E. Ribi. 1971. General Characterictics. 
p. 1-65. ̂  G. Weinbaum, S. Kadis, and S. Ajl (eds). Microbial 
Toxins, Vol IV. Academic Press, New York, NY. 
49. Morbidity and Mortality. 1973. Annual supplement. U. S. Department of 
Public Health, p. 13. Washington, DC. 
50. Novotny, P. and W. H. Turner. 1975. Immunological heterogeneity of pili 
of Neisseria gonorrhoeae. J. Gen. Microbiol. 89:87-92. 
51. Pierce, W. A. Jr., J. K. Leong, and D. M. Hough. 1975. Strain-specific 
virulence-associated antigen of Neisseria gonorrhoeae. Infect. 
Immun. 11:898-903. 
96 
52. Pimsalang, A. P., Jr. and W. D. Sawyer. 1973. Role of pili in the viru­
lence of Neisseria gonorrhoeae. Infect. Immun. 255-263. 
53. Reising, G. 1971. Microflocculation assay for gonococcal antibody. 
J. Appl. Microbiol. 852-853. 
54. Reising, G., J. D. Schmale, D. G. Danielsson, and J. D. Thayer. 1969. 
Reactivity of two selected antigens of Neisseria gonorrhoeae. 
Appl. Microbiol. 18:337-339. 
55. Reyn. A. 1969. Recent developments in the laboratory diagnosis of gono­
coccal infections. Bull. WHO. 40:254-255. 
56. Rudbach, J. A., F. I. Akiya, R. J. Elin, H. D. Hochstein, M. K. Luoma, 
E. C. B. Milner, K. C. Milner, and K. R. Thomas. 1976. Preparation 
and properties of a national reference endotoxin, J. Clin. Micro­
biol. 3:21-25. 
57. Schamle, J. D. 1970. Serologic detection of gonorrhea. In Editorials, 
Ann. Int. Med. 72:593-595. 
58. Schmale, J. D., D. G. Danielsson, J. F. Smith, L. Lee, and W. L. Peacock, 
Jr. 1969. Isolation of an antigen of Neisseria gonorrhoeae involved 
in the human immune response to gonococcal infection. J. Bacterid. 
469-471. 
59. Smith, R. T. and L. Thomas. 1956. The lethal effect of endotoxins on 
the chick embryo. J. Exp. Med. 104:217-231. 
60. Swanson, J., S. J. Kraus, and E. C. Gotschlich. 1971. Studies on gono-
coccus infection I. pili and zones of adhesion: Their relation to 
gonococcal growth patterns. J. Exp. Med. 134:886-906. 
61. Tauber, H. and W. Garson. 1957. Preparation and some properties of 
Neisseria gonorrhoeae endotoxin. Proc. Soc. Exp. Biol. Med. 
95:669-672. 
62. Thayer, J. D. and J. E. Martin. 1964. A selective medium for the culti­
vation of N. gonorrhoeae and N. meningitidis. Pub. Health Rep. 
79:49-57. 
63. Todays VD control problem. 1971. W. L. Fleming (chair.) American Social 
Health Association Rep. New York, NY. 
64. Tronca, E., H. H. Handsfield, P. J. Wiesner, and K. K. Holmes. 1974. 
Demonstration of Neisseria gonorrhoeae with fluorescent antibody 
in patients with disseminated gonococcal infection. J. Infect. 
Dis. 129:583-586. 
65. Warburg, 0., und W. Christian. 1942. Isolierung und kristallisation 
des gârungsferments enolase. Biochem. Z. 310:384-421. 
97 
66. Welch, B. G. and R. J. O'Reilly. 1973. An indirect fluorescent-antibody 
technique for study of uncomplicated gonorrhea. I. Methodology. 
J. Infect. Dis. 127:69-76. 
67. Wolff, S. M., J. H. Mulholland, S. B. Ward. 1965. Quantitative aspects 
of the pyrogenic response of rabbits to endotoxin. J. Lab. Clin. 
Med. 65:268-276. 
